Circulating sex hormone actions do not account for all sex differences in cancer as sexual differentiation in normal physiology affects male and female rate of growth, immunity, myelination, aging and metabolism, amongst other physiological changes [27]. This evidence concerns the gene PLXNA3 and cancer.